81 related articles for article (PubMed ID: 23518771)
1. Optimization of subconjunctival biodegradable microfilms for sustained drug delivery to the anterior segment in a small animal model.
Liu YC; Peng Y; Lwin NC; Wong TT; Venkatraman SS; Mehta JS
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2607-15. PubMed ID: 23518771
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery.
Ang M; Yan P; Zhen M; Foo S; Venkatraman SS; Wong TT
Curr Eye Res; 2011 Dec; 36(12):1123-8. PubMed ID: 22007761
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a prednisolone acetate-loaded subconjunctival implant for the treatment of recurrent uveitis in a rabbit model.
Ang M; Ng X; Wong C; Yan P; Chee SP; Venkatraman SS; Wong TT
PLoS One; 2014; 9(5):e97555. PubMed ID: 24842851
[TBL] [Abstract][Full Text] [Related]
4. A Biodegradable, Sustained-Released, Tacrolimus Microfilm Drug Delivery System for the Management of Allergic Conjunctivitis in a Mouse Model.
Liu YC; Ng XW; Teo EPW; Ang HP; Lwin NC; Chan NSW; Venkatraman SS; Wong TT; Mehta JS
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):675-684. PubMed ID: 29392313
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility and biodegradation studies of subconjunctival implants in rabbit eyes.
Peng Y; Ang M; Foo S; Lee WS; Ma Z; Venkatraman SS; Wong TT
PLoS One; 2011; 6(7):e22507. PubMed ID: 21799878
[TBL] [Abstract][Full Text] [Related]
6. A biodegradable, sustained-released, prednisolone acetate microfilm drug delivery system effectively prolongs corneal allograft survival in the rat keratoplasty model.
Liu YC; Peng Y; Lwin NC; Venkatraman SS; Wong TT; Mehta JS
PLoS One; 2013; 8(8):e70419. PubMed ID: 23940573
[TBL] [Abstract][Full Text] [Related]
7. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery.
Cui LJ; Sun NX; Li XH; Huang J; Yang JG
Acta Pharmacol Sin; 2008 Sep; 29(9):1021-8. PubMed ID: 18718170
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro/in vivo evaluation of cyclosporin A-loaded nanodecorated ocular implants for subconjunctival application.
Pehlivan SB; Yavuz B; Çalamak S; Ulubayram K; Kaffashi A; Vural İ; Çakmak HB; Durgun ME; Denkbaş EB; Ünlü N
J Pharm Sci; 2015 May; 104(5):1709-20. PubMed ID: 25716582
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
[TBL] [Abstract][Full Text] [Related]
10. A biodegradable drug delivery system for the treatment of postoperative inflammation.
Eperon S; Bossy-Nobs L; Petropoulos IK; Gurny R; Guex-Crosier Y
Int J Pharm; 2008 Mar; 352(1-2):240-7. PubMed ID: 18093765
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Sustained-Release Prednisolone Acetate Biodegradable Subconjunctival Implant in a Non-Human Primate Model.
Liu YC; Ng AHC; Ng XW; Yan P; Venkatraman SS; Mehta JS; Wong TT
Transl Vis Sci Technol; 2017 Sep; 6(5):9. PubMed ID: 29046829
[TBL] [Abstract][Full Text] [Related]
12. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment.
Voss K; Falke K; Bernsdorf A; Grabow N; Kastner C; Sternberg K; Minrath I; Eickner T; Wree A; Schmitz KP; Guthoff R; Witt M; Hovakimyan M
J Control Release; 2015 Sep; 214():1-11. PubMed ID: 26160303
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility of different poly(lactide-coglycolide) polymers implanted into the subconjunctival space in rats.
Rönkkö S; Kaarniranta K; Kalesnykas G; Uusitalo H
Ophthalmic Res; 2011; 46(2):55-65. PubMed ID: 21228610
[TBL] [Abstract][Full Text] [Related]
15. Sustained-release voriconazole-thermogel for subconjunctival injection in horses: ocular toxicity and in-vivo studies.
Mora-Pereira M; Abarca EM; Duran S; Ravis W; McMullen RJ; Fischer BM; Lee YP; Wooldridge AA
BMC Vet Res; 2020 Apr; 16(1):115. PubMed ID: 32295599
[TBL] [Abstract][Full Text] [Related]
16. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
[TBL] [Abstract][Full Text] [Related]
17. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
Okabe K; Kimura H; Okabe J; Ogura Y
Retina; 2007; 27(6):770-7. PubMed ID: 17621189
[TBL] [Abstract][Full Text] [Related]
18. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.
Jaffe GJ; Yang CH; Guo H; Denny JP; Lima C; Ashton P
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3569-75. PubMed ID: 11006254
[TBL] [Abstract][Full Text] [Related]
19. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y
Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
[TBL] [Abstract][Full Text] [Related]
20. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
